<DOC>
	<DOCNO>NCT01528514</DOCNO>
	<brief_summary>It well-established myocardial infarction ( MI ) associate coronary artery bypass graft surgery ( CABG ) predict poor outcome . Nevertheless , cardioprotective therapy limit myocardial injury CABG lacking . Previous study show curcuminoids suppress pro-inflammatory cytokine cardiopulmonary bypass surgery decrease occurrence cardiomyocytic apoptosis cardiac ischemia/reperfusion injury animal model . The investigator aim evaluate whether curcuminoids prevent MI CABG , compare placebo .</brief_summary>
	<brief_title>Effects CUrcuminoids Coronary Artery byPass graftIng-related myocarDial Infarction Study</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Patients undergo CABG without valve surgery emergency cardiac surgery increase CKMB upper limit normal range ( ULN ) time randomization patient cholestatic jaundice ( total bilirubin &gt; 2fold ULN ) severe liver disease ( AST ALT &gt; 3fold ULN )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Myocardial infarction</keyword>
	<keyword>Coronary artery bypass grafting</keyword>
	<keyword>Anti-oxidant</keyword>
	<keyword>Curcuminoids</keyword>
</DOC>